Esperion Therapeutics Stock Price on February 11, 2022
| ESPR Stock | USD 1.84 0.07 3.66% |
Below is the normalized historical share price chart for Esperion Therapeutics extending back to June 26, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Esperion Therapeutics stands at 1.84, as last reported on the 18th of April 2024, with the highest price reaching 1.96 and the lowest price hitting 1.81 during the day.
If you're considering investing in Esperion Stock, it is important to understand the factors that can impact its price. Esperion Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0022, which denotes the company had a -0.0022% return per unit of risk over the last 3 months. Esperion Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Esperion Therapeutics' Mean Deviation of 4.49, variance of 32.72, and Standard Deviation of 5.72 to check the risk estimate we provide.
At this time, Esperion Therapeutics' Common Stock Total Equity is relatively stable compared to the past year. As of 04/18/2024, Common Stock Shares Outstanding is likely to grow to about 108.3 M, though Treasury Stock is likely to grow to (47 M). . As of 04/18/2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 2.52. Esperion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2013 | 200 Day MA 1.7714 | 50 Day MA 2.4982 | Beta 0.822 |
Esperion |
Sharpe Ratio = -0.0022
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ESPR |
Estimated Market Risk
| 5.27 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Esperion Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Esperion Therapeutics by adding Esperion Therapeutics to a well-diversified portfolio.
Price Book 74.8863 | Enterprise Value Ebitda (3.86) | Price Sales 3.4041 | Shares Float 184 M | Wall Street Target Price 7.41 |
Esperion Therapeutics Valuation on February 11, 2022
It is possible to determine the worth of Esperion Therapeutics on a given historical date. On February 11, 2022 Esperion was worth 5.0 at the beginning of the trading date compared to the closed value of 5.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Esperion Therapeutics stock. Still, in general, we apply an absolute valuation method to find Esperion Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Esperion Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Esperion Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
04/04/2022 | 5.00 | 5.36 | 4.94 | 5.25 | 1,419,000 |
| 5.25 | 5.48 | 5.14 | 5.38 | 1,463,200 |
| Backtest Esperion Therapeutics | | | Esperion Therapeutics History | | | Esperion Therapeutics Valuation | Next |
Esperion Therapeutics Trading Date Momentum on February 11, 2022
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Esperion Therapeutics Fundamentals Correlations and Trends
By evaluating Esperion Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Esperion Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Esperion financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Esperion Therapeutics Stock history
Esperion Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Esperion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Esperion Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Esperion Therapeutics stock prices may prove useful in developing a viable investing in Esperion Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 103.1 M | 108.3 M | |
| Net Loss | -210.3 M | -220.8 M |
Esperion Therapeutics Quarterly Net Working Capital |
|
Esperion Therapeutics Stock Technical Analysis
Esperion Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Esperion Therapeutics Period Price Range
Low | April 4, 2022
| High |
5.00 | 5.25 |
Esperion Therapeutics April 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Esperion Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Esperion Therapeutics shares will generate the highest return on investment. By undertsting and applying Esperion Therapeutics stock market strength indicators, traders can identify Esperion Therapeutics entry and exit signals to maximize returns
| Accumulation Distribution | 111190.0 | |||
| Daily Balance Of Power | 0.5952 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 5.15 | |||
| Day Typical Price | 5.18 | |||
| Price Action Indicator | 0.22 | |||
| Period Momentum Indicator | (3.41) |
Esperion Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Esperion Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Esperion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Esperion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | (0.41) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Esperion Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Esperion Stock analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Esperion Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Esperion Therapeutics. If investors know Esperion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Esperion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.03) | Revenue Per Share 1.128 | Quarterly Revenue Growth 0.714 | Return On Assets (0.43) | Return On Equity (2.61) |
The market value of Esperion Therapeutics is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Esperion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Therapeutics' market value can be influenced by many factors that don't directly affect Esperion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Esperion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.